Apart from the solid body of evidence in favour of a therapeutic role for BMP-7 in chronic kidney conditions in terms of anti-inflammatory and anti-fibrotic outcome, evidence is also emerging for other effects of BMP-7 which may contribute to patient symptomatic management in SLE and LN. This evidence concerns the gene BMP7 and lobular neoplasia.